Symmetric
  • TRAINING COURSES
  • IN-HOUSE TRAINING
  • CLIENTS
  • TRAINERS
  • BLOG
  • ABOUT US
  • CONTACT

Join Symmetric Newsletter

Sign up today so you don't miss any special offers, new events and pharma breaking news.

TOP 3 Pharma & Biotech Worldwide News Once a Month

Interviews With Industry Professionals Once Every Three Months

Regular Event Calendar & Special Offers Once Every Six Months

Symmetric s.r.o.

Mliekarenska 7

82109 Bratislava

Slovak Republic

ID: 47 068 124

VAT No: SK2023741973

Office: +421 948 262 346

LinkedIn

Booking & Support

Phone (EU):+421 948 262 346 (9:00 - 17:00 CET)

Phone (US):+1 857 392 2714 (9:00 - 16:00 ET)

Email:info@symmetric.events

A real member of our team answers our chat

Terms & ConditionsPrivacy PolicyChange Your Cookie Consent

© 2026 Symmetric s.r.o.

CMC Regulatory Compliance for Biologics: A CMC approach to IMPD Walkthrough for Biologics
CMC
Pharma & Biotech

CMC Regulatory Compliance for Biologics: A CMC approach to IMPD Walkthrough for Biologics

29 April – 1 May 2026

Price available after dates are announced

TRAINING TIMES

  • 12:00 - 17:00Vienna
  • 11:00 - 16:00London
  • 06:00 - 11:00New York
  • 03:00 - 08:00Los Angeles
Online Training

WHY SHOULD YOU ATTEND?

Master Regulatory & CMC Requirements

Gain clarity on IMPD/CTD structures, ICH quality guidelines, and data expectations for both drug substance and drug product.

Navigate the Development Pathway

From cell line development to fill-finish, learn how to manage analytical validation, stability studies, and reference standards effectively.

Build Robust Quality & Control Strategies

Apply QbD principles to design lifecycle control strategies, manage process risks, and ensure consistent product quality.

Execute Tech Transfer & Avoid Pitfalls

Plan and manage technology transfer, process validation, and change control while recognising common regulatory challenges unique to biologics.


OUR ONLINE TRAINING EXPERIENCE INCLUDE

Two days of expert-led Zoom sessions packed with discussions, Q&As, and real-world scenarios.

All slides, tools, and supporting materials available in our CLIENT ZONE before, during, and after the course.

Receive a digital certificate (also Linkedin-ready) that verifies your skills in strategic trial planning.


LEARNING OBJECTIVES

Learning Objective

Regulatory Update

Understand the regulatory structure of the IMPD and CTD, and how it applies to biologic product development

Learning Objective

Quality

Apply ICH quality guidelines and Develop a clear control strategy using QbD

Learning Objective

Process

From cell line development through to drug product and clinical submission. Manage a plan for effective tech transfer, process validation, scale-up and change

Learning Objective

Pitfalls and Regulatory Interactions

Identify common regulatory pitfalls and strategies to avoid them


WHO IS THIS TRAINING FOR?

Designed for professionals who want to enhance their expertise and advance their careers

Regulatory Affairs

CMC Professionals

Quality Control/ Assurance Personnel

Manufacturing Engineers and Managers

Research and Development Scientists

Project Managers


KEY TOPICS

IMPD/CTD Walkthrough: Overview of Module 1 - 5
Manufacturing and Process Development
Tech Transfer: Planning, documentation, CDMO coordination
CTD Module 3: DS & DP data requirements
Stability Studies: ICH Q guidance, real-time and accelerated data
Analytical Development: Methods, validation, comparability, critical quality attributes (CQAs)
Reference Standards: Sourcing, characterisation, qualification
Change Management: Tools for managing post-approval changes

TRAINER

Dr. Len Pattenden

Dr. Len Pattenden

CMC Expert and Independent Consultant Len has over 30 years of experience in both industry and academia. He is a member of a regulatory advisory group for ATMPs. Len has been a company founder, COO and GMP site head/license holder, overseeing biopharma development and manufacture as well as outsourced CDMO activities. Len has undertaken development and manufacturing of 18 new biological entities, including first-in-man/first-in-class cell and gene therapies, viral vectors, biologics, and monoclonal antibodies. Len’s regulatory and licensing experience covers the MHRA, EMA and FDA. Len works as a CMC consultant for small and large pharmaceutical companies.

Learn More →

Video Invitation

Watch the video invitation from the trainer.

Sneak peek

Sneak Peek

Take a sneak peek at the trainer's presentation.

View PDF →